Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-Hodgkin Lymphoma
100%
Lymphoma
100%
AIDS-related
100%
Specific Factors
100%
AIDS-related Lymphoma
100%
Age-adjusted
66%
HIV Patients
66%
Overall Survival
66%
HIV-related
66%
Prognostic Factors
66%
Phase I Trial
66%
Aggressive non-Hodgkin Lymphoma
66%
International Prognostic Index
66%
Contemporary Era
66%
Significant Predictors
33%
Poor Outcome
33%
Diffuse Large B-cell Lymphoma (DLBCL)
33%
Logistic Regression
33%
North America
33%
North Europe
33%
Cox Proportional Hazards Model
33%
CD4 Count
33%
Pooled Analysis
33%
Patient-level Data
33%
Individual Patient Data
33%
Direct Therapy
33%
Complete Response
33%
Progression-free Survival
33%
Anti-lymphoma
33%
Outcome Prediction
33%
Burkitt Lymphoma
33%
Complete Response Rate
33%
Immuno
33%
Risk Category
33%
Prospective Phase II Study
33%
Low CD4
33%
Baseline CD4 Count
33%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
100%
Non-Hodgkin Lymphoma
100%
Overall Survival
28%
Prognostic Factor
28%
International Prognostic Index
28%
Clinical Trial
14%
Diffuse Large B-Cell Lymphoma
14%
Patient-Data
14%
Immunotherapy
14%
Logistic Regression Analysis
14%
Systematic Review
14%
Progression Free Survival
14%
Proportional Hazards Model
14%
Pooled Analysis
14%
Burkitt's Lymphoma
14%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
100%
CD4 Lymphocyte Count
28%
Overall Survival
28%
Immunotherapy
14%
B Cell
14%
Progression Free Survival
14%
Patient Coding
14%